Juvenile idiopathic arthritis (JIA) is an umbrella term for arthritis of unknown origin, lasting
for> 6 weeks with onset before 16 years of age. JIA is the most common chronic …

Juvenile idiopathic arthritis is a heterogeneous group of diseases characterised by arthritis
of unknown origin with onset before age of 16 years. Pivotal studies in the past 5 years have …

To develop evidence based points to consider the use of imaging in the diagnosis and
management of juvenile idiopathic arthritis (JIA) in clinical practice. The task force comprised …

Juvenile idiopathic arthritis (JIA) is not a disease but an exclusion diagnosis that includes all
forms of chronic arthritis of unknown origin with onset before 16 years of age. The current …

Juvenile idiopathic arthritis (JIA) is a heterogeneous group of diseases characterized by
synovial inflammation and is the most common rheumatic complaint in children. To facilitate …

Imaging assessments of the joints of children with juvenile idiopathic arthritis (JIA) are
challenging, owing to the unique features of the growing skeleton. Traditionally, imaging …

Juvenile idiopathic arthritis (JIA) represents a group of heterogeneous diseases
characterized by a chronic inflammatory process primarily targeting the synovial membrane …

Objectives During a multicentre study on juvenile idiopathic arthritis, wide variations were
observed in bone shape, signal intensity and volume of joint fluid as shown by MRI which in …

Here we report the use of denosumab, a monoclonal antibody against receptor activator of
nuclear factor κB ligand (RANKL), as monotherapy for multicentric carpotarsal osteolysis …

In recent years, imaging has become increasingly important to confirm diagnosis, monitor
disease activity, and predict disease course and outcome in children with juvenile idiopathic …